Results

Total Results: 1,170 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

221. Clinical Effectiveness of Coronary Stents in the Elderly: Results From 262,700 Patients in the American College of Cardiology-National Cardiovascular Data Registry | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-stents-outcomes/research
     February 10, 2010 - Thus we are unable to directly address some important questions which have been raised regarding the safety … Effectiveness and Safety of Drug-Eluting Stents in Ontario. N Engl J Med 2007;357:1393-1402. … Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention … Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. … Unadjusted baseline characteristics of patients in study population Patient Characteristics Study

222. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
     March 01, 2012 - Despite recent advances in patient care, fatal pulmonary embolism occurs in 0.1 - 0.5% of these patients … A separate question is whether there are patient risk factors associated with VTE events in patients … We propose the following rubric: 1, Efficacy; 2, Safety; 3, Cost. … 2) Improved Efficacy; No improvement in Safety 3) No improvement in Efficacy; Improved Safety 4) No … Furthermore, in the clinical trials, highly selected patient groups were used (excluding patients felt

223. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - balloon removal from other teams’ patients (3 patients, 0.11%), and at 1 patient (0.03%) each, Wernick … Patients were reported to have generally tolerated the balloon well, with one early removal for patient … greatly and limit patient acceptance, although patient interest in the procedure would likely remain … Perioperative safety in the longitudinal assessment of bariatric surgery. … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81.

224. What is the comparative renal of differnt contrast media used in radiographic imaging ? What is the comparative efficacy of different therapies in preventing contrast induced nephropathy? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-renal-of-differnt-contrast-media-used-in-radiographic-imaging-what-is-the-comparative-efficacy-of-different-therapies-in-preventing-contrast-induced-nephropathy
     December 30, 2011 - the specific technologies, devices, drugs, or interventions you would like to see compared: Renal safety … or group(s) of patients does your question apply to? … Patients undergoing coroanry angiography and interventions Are there subgroups of patients that your … Patients with renal dysfunction Patients with diabetes Describe the health-related benefits you … (For example, improvements in patient symptoms or problems from treatment or diagnosis.)

225. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
     October 18, 2010 - Terbutaline sulfate is commonly used in selected patients as a maintenance therapy to inhibit uterine … Further, as the level of care offered to patients and the level of activity of patients on continuous … subcutaneous terbutaline might differ from that of patients on comparative treatments, we will explore … Therefore, in addition to conducting heterogeneity analyses by other indicators of true preterm labour … to ensure only one event is recorded per patient, in the case the same patient experiences multiple

226. Making Sure That Evidence Is Understood and Used (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-making-sure-evidence-understood.pdf
     July 01, 2020 - Department of Health and Human Services that is charged with improving the quality, safety, efficiency … What information is needed to make better recommendations to patients? … Consumers, patients, caregivers, and patient advocacy organizations It is vital that research answer … with accurate, independent, scientifically rigorous information for comparing the effectiveness and safety … Patient, Population or Problem: ◆ The “P” in PICO(TS) is a description of the patient(s) of interest

227. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - every other week, for the life of the patient. … What are the potential safety issues and harms with ERT? 2. … What published and unpublished studies have reported on the use and safety of this intervention? … Adverse events/harms/safety issues reported 4. … patient and one parent of a child patient will be consulted.

228. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - In patients with chronic plaque psoriasis, what is the comparative safety of systemic biologic agents … To be included, the patient population evaluated in the study must have been adult patients (≥18 years … In an RCT that compared the efficacy and safety of adalimumab with placebo in patients with moderate … Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate … Safety and efficacy study on etanercept in patients with plaque psoriasis.

229. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - The workgroup suggests that EPC reviews focus on indicators of more severe harms (e.g., “serious” adverse … 9) How should input from technical and clinical experts and patients or patient advocacy groups be used … How should input from technical and clinical experts and patients or patient advocacy groups be used … Had to report data from groups of in which at least 85% of the patients were from one of the patient … What are the harms of therapeutic interventions for patients with ME/CFS and how do they vary by patient

230. Prioritization and Selection of Harms for Inclusion in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
     February 01, 2018 - 2016. http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm (accessed October 2, 2017) 1. … Eliciting patient perspective in patient-centered outcomes research: a meta narrative systematic review … Eliciting patient perspective in patient-centered outcomes research: a meta narrative systematic review … EPC reviews should focus on indicators of more severe harms as it is more difficult to interpret the … Eliciting patient perspective in patient-centered outcomes research: a meta narrative systematic review

231. Vitamin D and Calcium: A Systematic Review of Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
     June 10, 2013 - states) and physicians’ increasing use of laboratory tests to assess vitamin D and calcium status among patients … Arrow 4 indicates the association between exposure and indicators of exposure. … that might include some people with diseases of concern—for example, some hypertensive and diabetic patients—will … Efficacy and safety data will be abstracted by the statistical analyst and confirmed by the co-project … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing

232. Vte-Prophyalaxis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
     May 01, 2013 - The burden of VTE is higher among some patient populations, including patients who have experienced … and safety of pharmacologic strategies for VTE prevention in patients with liver disease. … effectiveness and safety of pharmacologic strategies among patients with liver disease. … in the patient populations. … RCTs should evaluate the comparative effectiveness and safety of LMWHs in obese patients.

233. Venous-Ulcers-Treatment-Future Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
     January 01, 2014 - with patient dropouts. … retention Patients Standardized characterization and reporting of patient and wound characteristics … It is also extremely painful to the patient. … Population Standards for Describing Participating Patients and Their Ulcers Reporting of patient characteristics … , patient-reported and other secondary outcomes.

234. S131 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
     October 01, 2007 - Presented at the Agency for Healthcare Research and Quality meeting on “Comparative Effectiveness and Safety … competitors within a class are often marketed for better efficacy, slightly expanded indications, or better safety … Baseline patient characteristics are presented in Table 1. … the effectiveness and safety of a particular drug that I am about to start and continue to use, compared … , we identified a set of restrictions that analysts should consider in epidemiologic studies of the safety

235. Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
     November 01, 2022 - Background and Purpose, I disagree saying the 911 workers have contact with the public and multiple patients … of the background section to indicate that public-facing EMS clinicians have contact with multiple patients … o acknowledge that exposures may result from activities not involving direct contact with patients … ) evaluation of strategies implemented by 911 call centers that aid in the detection of infectious patients … The Needlestick Safety & Prevention Act of 2000 was passed by the U.S.

236. Closing the Quality Gap Series: The Patient-Centered Medical Home | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/patient-centered-medical-home/research-protocol
     February 23, 2012 - as a way of improving patient experiences, outcomes, safety, and system efficiency. 10-12 It is based … Clinical outcomes: Intermediate patient outcomes (e.g., change in HbA1c for diabetic patients). … A systems-based approach to quality, safety, and delivery of evidence-based care. … Clinical outcomes: Intermediate patient outcomes (e.g., change in HbA1c for diabetic patients). … care, superb access to care, and a systems-based approach to quality and safety.

237. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - KQ 2: For patients with PAH, what are the comparative effectiveness and safety of (a) echocardiography … KQ 3: For patients with PAH, what are the comparative effectiveness and safety of monotherapy or combination … We found no studies describing the safety (or harms) of echocardiography or biomarker testing. … Twenty-eight RCTs involving 3,613 patients evaluated the comparative effectiveness and safety of monotherapy … The mean patient ages ranged from 28 to 50 years old.

238. Non-Pharmacologic Interventions for Treatment-resistant Depression in Adults — Research Protocol Document | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/treatment-resistant-depression/research-protocol
     December 09, 2009 - when the patient is treatment resistant. … For adults with treatment-resistant depression, do non-pharmacologic interventions differ in safety, … Comparators: ECT, rTMS, VNS, demonstrated effective psychotherapy Outcomes for each question Safety … KQ4 focuses on safety issues (adverse effects, adherence) with each of the interventions. … While the patient is ultimately the one to make the decision about whether to receive the non-pharmacologic

239. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
     December 09, 2009 - when the patient is treatment resistant. … For adults with treatment-resistant depression, do non-pharmacologic interventions differ in safety, … Comparators: ECT, rTMS, VNS, demonstrated effective psychotherapy • Outcomes for each question • Safety … KQ4 focuses on safety issues (adverse effects, adherence) with each of the interventions. … While the patient is ultimately the one to make the decision about whether to receive the non- pharmacologic

240. Ch 8-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
     October 01, 2013 - ablation for hepatocellular carcinoma compared to resection or no treatment5 and a comparison of the safety … Diagnoses or procedures coded for payment No Yes Behavioral risk factors Yes* No Diet Sometimes* No Indicators … missing biochemistry lab data compared to early-stage patients (6-9% incomplete in early-stage patients … Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. … Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems